SR2B's Acquisition

SR2B was acquired by Biosynex Group on June 07, 2017.

SR2B specializes in the design of parasitic serological tests, the formulation of solutions for the parasitological examination of stools and the development of culture media in mycology.…

Articles about SR2B's Acquisition: